Your browser doesn't support javascript.
loading
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Kuter, David J; Rogers, Kerry A; Boxer, Michael A; Choi, Michael; Agajanian, Richy; Arnold, Donald M; Broome, Catherine M; Field, Joshua J; Murakhovskaya, Irina; Numerof, Robert; Tong, Sandra.
Afiliação
  • Kuter DJ; Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Rogers KA; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Boxer MA; Division of Hematology-Oncology, Arizona Oncology, Tucson, Arizona, USA.
  • Choi M; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Agajanian R; Division of Hematology-Oncology, The Oncology Institute of Hope and Innovation, Downey, California, USA.
  • Arnold DM; Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Broome CM; Lombardi Cancer Center, Division of Hematology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
  • Field JJ; Blood Center of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Murakhovskaya I; Department of Medicine (Hematology), Albert Einstein College of Medicine, Bronx, New York, USA.
  • Numerof R; Development and Medical Affairs, Rigel Pharmaceuticals, Inc, South San Francisco, California, USA.
  • Tong S; Development and Medical Affairs, Rigel Pharmaceuticals, Inc, South San Francisco, California, USA.
Am J Hematol ; 97(6): 691-699, 2022 06 01.
Article em En | MEDLINE | ID: mdl-35179251

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anemia Hemolítica Autoimune Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article